Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Angers
Age
1–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
* Children aged from 1 to 18 years at the time of first B-ALL relapse diagnosis
* Obtention of oral and written consent of the parents
* Parents affiliated with the social security system
* Children aged from 1 to 18 years enrolled into FRALLE or EORTC treatment protocols, treated for B-ALL and who are in complete molecular remission
* Obtention of oral and written consent of the parents
* Parents affiliated with the social security system
You may not be if
* Children with hematologic syndrome predisposing to hematologic neoplasia (such as Fanconi's anaemia, Diamond Blackfan anaemia …) or acute leukemia secondary to previous treatment, or who have had allogenic hematopoietic stem cell transplantation before relapse
Clareo Health | Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
